Dutch fuel on the fire.

There are few routine lab controversies more heated than the role of prostate-specific antigen (PSA) screening for otherwise healthy middle-age men. The ERSPC Rotterdam trial now has 20-year results demonstrating that routine PSA screening every 4 years for men ages 55 to 75 slashes incidence of prostate cancer metastases and mortality in half. | Osses, Eur Urol 2018

Comments

  1. I will be happy if you read my comment. I must say that I like all your posts and wait for new ones. That's because they seem so great and suitable for me. Thanks a ton for uploading your articles.
    jogos friv online
    friv school Games to play
    a10 best free online game


    ReplyDelete

Post a Comment

Popular Posts